Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Oct 26, 2021; 9(30): 9023-9037
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9023
Table 2 The expert scores from the second round of the consultations
First-level indices
Second-level indices
mean ± SD
CV%
LocationJunctional4.87 ± 0.340.07
Mobile4.47 ± 0.500.11
Semirigid3.53 ± 0.620.17
Rigid3.07 ± 0.440.14
Lesion-free 2.47 ± 0.810.33
Level of painRecalcitrant pain in the corresponding zone (not relieved after chemotherapy) VAS > 74.80 ± 0.400.08
Moderate pain in the corresponding zone (not relieved after chemotherapy) VAS 4-74.47 ± 0.490.11
Mild pain in the corresponding zone (VAS = 3 after chemotherapy)3.67 ± 0.480.13
Mild pain during activity (VAS ≤ 2 after chemotherapy) no rest pain3.20 ± 0.400.12
No pain during activity after chemotherapy2.67 ± 0.940.35
Number of segments> 3 4.93 ± 0.250.05
34.87 ± 0.560.11
24.67 ± 0.790.17
13.80 ± 0.990.26
No change in morphology2.73 ± 0.100.36
physiological curvature
Lateral radiographPhysiological curvature of the lesion is abnormal4.67 ± 0.470.10
Physiological curvature of the lesion is normal3.00 ± 0.520.17
Front radiographScoliosis/rotation4.80 ± 0.400.08
No scoliosis/rotation3.00 ± 0.520.17
ComorbiditiesSpondylolisthesis ( 1 degree) 4.87 ± 0.340.07
Shift/dislocation (0-1degree)4.53 ± 0.620.14
Herniated disk3.93 ± 0.440.11
Bone spurs3.13 ± 0.500.16
Bony fusion2.80 ± 0.540.19
Neurological functionFrankel A5.00 ± 0.000.00
Frankel B4.87 ± 0.340.07
Frankel C4.73 ± 0.440.09
Frankel D4.07 ± 0.250.06
Frankel E2.87 ± 0.340.12